Disciplined Equity Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
86,560
-70
-0.1% -$1.83K 0.92% 15
2026
Q1
$2.43M Buy
86,630
+1,460
+2% +$38.9K 1.22% 9
2025
Q4
$2.12M Sell
85,170
-780
-0.9% -$19.7K 1.1% 11
2025
Q3
$2.19M Sell
85,950
-1,100
-1% -$27.1K 1.19% 10
2025
Q2
$2.11M Buy
87,050
+14,290
+20% +$333K 1.24% 12
2025
Q1
$1.84M Buy
72,760
+8,320
+13% +$218K 1.28% 13
2024
Q4
$1.71M Buy
64,440
+200
+0.3% +$5.42K 1.11% 13
2024
Q3
$1.86M Sell
64,240
-3,600
-5% -$105K 1.17% 15
2024
Q2
$1.9M Buy
67,840
+920
+1% +$25.3K 1.25% 13
2024
Q1
$1.86M Buy
66,920
+64,510
+2,677% +$1.79M 1.23% 14
2023
Q4
$69.4K Buy
2,410
+2,200
+1,048% +$66.5K 0.05% 70
2023
Q3
$6.97K Hold
210
0.01% 52
2023
Q2
$7.7K Hold
210
0.01% 52
2023
Q1
$8.57K Sell
210
-14,643
-99% -$632K 0.01% 52
2022
Q4
$761K Hold
14,853
0.67% 25
2022
Q3
$650K Sell
14,853
-10,950
-42% -$532K 0.64% 30
2022
Q2
$1.35M Buy
25,803
+8,250
+47% +$420K 1.23% 16
2022
Q1
$909K Sell
17,553
-27,990
-61% -$1.45M 0.91% 26
2021
Q4
$2.69M Buy
+45,543
New +$2.26M 2.6% 5

Other funds holding PFE

Disciplined Equity Management's PFE Position: Q2 2026 in Review

Disciplined Equity Management reduced its Pfizer (PFE) stake by 0.08% in Q2 2026, selling an estimated $1.83K and leaving 86,560 shares worth $2.08M. The position accounts for 0.92% of the portfolio, ranked #15.

Disciplined Equity Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.69M in Q4 2021. 1,257 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Disciplined Equity Management held 86,560 shares of Pfizer worth $2.08M as of Q2 2026.
  • Disciplined Equity Management sold 70 Pfizer shares in Q2 2026, an estimated $1.83K.
  • Pfizer made up 0.92% of Disciplined Equity Management's portfolio in Q2 2026, its #15 holding.
  • Disciplined Equity Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Disciplined Equity Management's Pfizer position peaked at $2.69M in Q4 2021.
  • 1,257 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Disciplined Equity Management's 13F filing for Q2 2026, filed 29 Jul 2026.